SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

The COVID Moonshot consortium

Research output: Contribution to journalArticlepeer-review

168 Scopus citations

Abstract

Kidney failure is frequently observed during and after COVID-19, but it remains elusive whether this is a direct effect of the virus. Here, we report that SARS-CoV-2 directly infects kidney cells and is associated with increased tubule-interstitial kidney fibrosis in patient autopsy samples. To study direct effects of the virus on the kidney independent of systemic effects of COVID-19, we infected human-induced pluripotent stem-cell-derived kidney organoids with SARS-CoV-2. Single-cell RNA sequencing indicated injury and dedifferentiation of infected cells with activation of profibrotic signaling pathways. Importantly, SARS-CoV-2 infection also led to increased collagen 1 protein expression in organoids. A SARS-CoV-2 protease inhibitor was able to ameliorate the infection of kidney cells by SARS-CoV-2. Our results suggest that SARS-CoV-2 can directly infect kidney cells and induce cell injury with subsequent fibrosis. These data could explain both acute kidney injury in COVID-19 patients and the development of chronic kidney disease in long COVID.

Original languageEnglish
Pages (from-to)217-231.e8
JournalCell stem cell
Volume29
Issue number2
DOIs
StatePublished - Feb 3 2022

Keywords

  • COVID-19
  • SARS-CoV-2
  • chronic kidney disease
  • fibrosis
  • human iPSC kidney organoids
  • kidney injury
  • protease blocker

Fingerprint

Dive into the research topics of 'SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids'. Together they form a unique fingerprint.

Cite this